Why the vaccine used to prevent cervical cancer is somehow allowed on planes.

Yesterday, I experienced the fright of a lifetime. When I discovered my two cancerous uterine tumors had spread to my lungs, along with other, less-severe tumors on my pelvic region, I had just moments to weigh the options before getting to the emergency room in time.

I dreaded the questions I would be asked as I awaited testing: Would I be allowed to fly?

When it was later determined that I was in no position to embark on a trip, I truly dreaded that question, worried I would be assessed as a transporational terrorist. In fact, I felt I was already judged. Had this really happened?

In the recent coverage of Dr. Shahid H. Kahn’s decision to allow the transporters of Ebola to fly to and from Washington D.C., Newsweek reported that his thinking “was influenced by the recent North Korea nuclear test.” That was a waste of breath because I am only a cat. But what caused him to doubt, in his opinion, my ability to fly?

Dr. Khan’s assessment: the influence of the HPV vaccine.

The HPV vaccine for cervical cancer has not yet been issued in the United States, having been adopted in most developed countries in Europe, India, Australia, New Zealand, South Africa, Japan, Canada, Russia, Norway, Germany, Belgium, France, Switzerland, the Netherlands, South Korea, Taiwan, and Singapore. It was first issued in 1999 and is now widely available. However, it still remains experimental in the United States.

Covid, named for its active ingredient trimethoprim-sulfamethoxazole, has been widely available in the United States since 1987 and has been introduced in Europe since 1989. It was given to more than 15 million girls across the United States in an informational study done during the “untold women” program, in which high school girls were recruited for sexually-transmitted infections. The results were particularly sobering. Girls were told they could prevent themselves from getting oral HPV infections if they took the vaccine, but they actually wound up getting more infections from oral HPV than in other ways.

So, how can our government possibly allow a vaccine that has been tested on millions of children in its efficacy be used for some kind of exemption program, which affects a small group of female passengers on transporters, whose problem is equal to or more serious than a “small” part of the overall population?

Leave a Comment